Certified Advisory Corp Novartis Ag Transaction History

Certified Advisory Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $42,875 - $47,357	-503 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$83.5 - $98.47 $16,533 - $19,497	-198 Reduced 28.25%	503 $43,000
Q2 2020 Jul 27, 2020	BUY	$80.93 - $91.1 $80 - $91	1 Added 0.14%	701 $61,000
Q1 2020 Apr 27, 2020	BUY	$70.67 - $99.01 $141 - $198	2 Added 0.29%	700 $58,000
Q2 2019 Aug 07, 2019	SELL	$75.4 - $92.8 $7,540 - $9,280	-100 Reduced 12.53%	698 $64,000
Q1 2019 May 07, 2019	BUY	$75.32 - $86.15 $150 - $172	2 Added 0.25%	798 $77,000
Q3 2018 Nov 13, 2018	SELL	$66.94 - $77.43 $5,221 - $6,039	-78 Reduced 8.92%	796 $69,000
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $259 - $293	4 Added 0.46%	874 $66,000
Q1 2018 Apr 30, 2018	BUY	$70.39 - $84.15 $42,234 - $50,490	600 Added 222.22%	870 $70,000
Q4 2017 Feb 22, 2018	BUY	$72.33 - $77.64 $19,529 - $20,962	270	270 $22,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Certified Advisory Corp with notifications on news.